申请人:Societe Anonyme dite: Hexachimie
公开号:US03989722A1
公开(公告)日:1976-11-02
The invention relates to 1-aminomethyl-2,2-diaryl cyclopropane carboxamides of the general formula ##SPC1## In which R represents the hydrogen atom, a halogen atom or a lower alkyl group or a lower alkoxy group; R.sub.1 and R.sub.2 which may be the same or different each represent a hydrogen atom, a lower alkyl group, an aryl group or an aralkyl group, in addition to which R.sub.1 and R.sub.2 together can form with the nitrogen atom to which they are attached a heterocyclic group with 5 to 7 peaks capable of containing a second hetero atom and capable of being substituted, and to their addition salts as new industrial products. These products are suitable for therapeutic application, in particular in the treatment of Parkinson's disease.
该发明涉及一般式##SPC1##的1-氨甲基-2,2-二芳基环丙烷羧酰胺,其中R代表氢原子、卤原子或较低的烷基基团或较低的烷氧基团;R.sub.1和R.sub.2可以相同也可以不同,分别代表氢原子、较低的烷基基团、芳基或芳基烷基,另外R.sub.1和R.sub.2还可以与它们连接的氮原子形成含有5到7个峰的杂环基团,该杂环基团能够含有第二个杂原子并且能够被取代,并且其加盐物作为新的工业产品。这些产品适用于治疗应用,特别是在帕金森病的治疗中。